Arbutus Odd-Lot Tender Clears at $5.00: 99 Shares Lose 3.3%
Arbutus Biopharma ($ABUS) completed its $230 million Dutch-auction tender at $5.00 per share, the bottom of its $5.00-to-$5.75 range. The offer was heavily oversubscribed. Ordinary shareholders who tendered at or below the clearing price had only about 55.6% of their shares accepted. Qualifying odd-lot holders were exempt from proration and had all of their properly tendered shares purchased.… Read More »
